serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.223 Acids, Carbocyclic .
D02.241.223.200 Cinnamates .
D02.241.223.200.210 Coumaric Acids .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.663 Pyrans .
D03.383.663.283 Benzopyrans .
D03.383.663.283.446 Coumarins .
D03.383.663.283.446.139 Aminocoumarins .
D03.383.663.283.446.520 4-Hydroxycoumarins .
D03.383.663.283.446.520.914 Warfarin .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.127 Benzofurans .
D03.633.100.150 Benzopyrans .
D03.633.100.150.446 Coumarins .
D03.633.100.150.446.139 Aminocoumarins .
D03.633.100.150.446.520 4-Hydroxycoumarins .
D03.633.100.150.446.520.914 Warfarin .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Aminocoumarins .
Amino-Coumarins .
Amino Coumarins .
COUMARINS with an amino group, exemplified by NOVOBIOCIN. .
1.00
1241
 
Coumarins .
1,2-Benzo-Pyrones .
1,2-Benzopyrone Derviatives .
Benzopyran-2-ones .
Coumarin Derivatives .
Coumarines .
1,2 Benzo Pyrones .
1,2 Benzopyrone Derviatives .
1,2 Benzopyrones .
Benzopyran 2 ones .
Derivatives, Coumarin .
Derviatives, 1,2-Benzopyrone .
1,2-Benzopyrones .
Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. .
0.80
8310993
 
Coumaric Acids .
Acids, Coumaric .
Acids, Hydroxycinnamic .
Hydroxycinnamic Acids .
Hydroxycinnamic acid and its derivatives. Act as activators of the indoleacetic acid oxidizing system, thereby producing a decrease in the endogenous level of bound indoleacetic acid in plants. .
0.62
223824
 
Benzofurans .
Diphenylbenzofuran .
Coumarones .
Compounds that contain a BENZENE ring fused to a furan ring. .
0.59
2111207
 
Warfarin .
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one .
Aldocumar .
Apo-Warfarin .
Coumadin .
Coumadine .
Gen-Warfarin .
Marevan .
Tedicumar .
Warfant .
Warfarin Potassium .
Warfarin Sodium .
Potassium, Warfarin .
Sodium, Warfarin .
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. .
0.55
24517075